| Rank |
Title |
Year |
PubWeight™‹?› |
|
1
|
The NF-kappaB regulatory network.
|
2006
|
2.25
|
|
2
|
The correlation between prolonged corrected QT interval with the frequency of respiratory arrest, endotracheal intubation, and mortality in acute methadone overdose.
|
2014
|
1.99
|
|
3
|
A case of caffeine-induced coronary artery vasospasm of a 17-year-old male.
|
2012
|
1.70
|
|
4
|
Oxidative stress and diabetic cardiomyopathy: a brief review.
|
2001
|
1.59
|
|
5
|
A case of acute cardiomyopathy and pericarditis associated with methylphenidate.
|
2009
|
1.48
|
|
6
|
A prospective study on electrocardiographic findings of patients with organophosphorus poisoning.
|
2011
|
1.43
|
|
7
|
Values of using QTc and N-terminal fragment of B-type natriuretic peptide as markers for early detection of acute antipsychotic drugs-induced cardiotoxicity.
|
2011
|
1.40
|
|
8
|
Questionable conclusions in the article "Cardiovascular toxicity of Citrus aurantium in exercised rats".
|
2013
|
1.39
|
|
9
|
Cell death and diabetic cardiomyopathy.
|
2003
|
1.32
|
|
10
|
Dioxin exposure is an environmental risk factor for ischemic heart disease.
|
2001
|
1.27
|
|
11
|
Nanoparticle inhalation impairs coronary microvascular reactivity via a local reactive oxygen species-dependent mechanism.
|
2010
|
1.27
|
|
12
|
HAART drugs induce oxidative stress in human endothelial cells and increase endothelial recruitment of mononuclear cells: exacerbation by inflammatory cytokines and amelioration by antioxidants.
|
2004
|
1.25
|
|
13
|
Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis.
|
2007
|
1.20
|
|
14
|
Molecular and cellular mechanisms of anthracycline cardiotoxicity.
|
2007
|
1.17
|
|
15
|
Acute cardiovascular toxicity of sterilizers, PHMG, and PGH: severe inflammation in human cells and heart failure in zebrafish.
|
2013
|
1.17
|
|
16
|
Differential cardiopulmonary effects of size-fractionated ambient particulate matter in mice.
|
2010
|
1.14
|
|
17
|
Role of mtDNA lesions in anthracycline cardiotoxicity.
|
2007
|
1.14
|
|
18
|
Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes.
|
2007
|
1.13
|
|
19
|
Role of anthracyclines in the era of targeted therapy.
|
2007
|
1.13
|
|
20
|
NF-kappaB as an integrator of diverse signaling pathways: the heart of myocardial signaling?
|
2003
|
1.12
|
|
21
|
Dexrazoxane: how it works in cardiac and tumor cells. Is it a prodrug or is it a drug?
|
2007
|
1.12
|
|
22
|
Huffing-induced cardiomyopathy: a case report.
|
2012
|
1.11
|
|
23
|
The prevalence of type 2 diabetes and hypertension in Uygur and Kazak populations.
|
2008
|
1.11
|
|
24
|
Cardiovascular toxicity with highly active antiretroviral therapy: review of clinical studies.
|
2004
|
1.11
|
|
25
|
Nicotine enhances human vascular endothelial cell expression of ICAM-1 and VCAM-1 via protein kinase C, p38 mitogen-activated protein kinase, NF-kappaB, and AP-1.
|
2006
|
1.11
|
|
26
|
Cardiac mitochondrial compromise in 1-yr-old Erythrocebus patas monkeys perinatally-exposed to nucleoside reverse transcriptase inhibitors.
|
2005
|
1.11
|
|
27
|
Phosphorylation of thymidine and AZT in heart mitochondria: elucidation of a novel mechanism of AZT cardiotoxicity.
|
2004
|
1.11
|
|
28
|
Hypertension, cardiac hypertrophy, and impaired vascular relaxation induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin are associated with increased superoxide.
|
2008
|
1.10
|
|
29
|
Different global gene expression profiles in benzo[a]pyrene- and dioxin-treated vascular smooth muscle cells of AHR-knockout and wild-type mice.
|
2004
|
1.08
|
|
30
|
With which mechanism the overuse of energy drinks may induce acute myocardial ischemia?
|
2012
|
1.08
|
|
31
|
Activation of inflammatory mediators and potential role of ah-receptor ligands in foam cell formation.
|
2004
|
1.08
|
|
32
|
Elevations in cardiac troponin measurements: false false-positives: the real truth.
|
2001
|
1.08
|
|
33
|
Modification of environmental toxicity by nutrients: implications in atherosclerosis.
|
2005
|
1.07
|
|
34
|
The effect of saffron consumption on biochemical and histopathological heart indices of rats with myocardial infarction.
|
2010
|
1.07
|
|
35
|
Aryl hydrocarbon receptor null mice develop cardiac hypertrophy and increased hypoxia-inducible factor-1alpha in the absence of cardiac hypoxia.
|
2002
|
1.07
|
|
36
|
Heart rate variability in rodents: uses and caveats in toxicological studies.
|
2007
|
1.07
|
|
37
|
Letter to the editor in response to: The correlation between prolonged corrected QT interval with the frequency of respiratory arrest, endotracheal intubation, and mortality in acute methadone overdose.
|
2014
|
1.06
|
|
38
|
Genotyping the risk of anthracycline-induced cardiotoxicity.
|
2007
|
1.06
|
|
39
|
Analysis of the Albumin Cobalt Binding (ACB) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction.
|
2001
|
1.05
|
|
40
|
Protection by flavonoids against anthracycline cardiotoxicity: from chemistry to clinical trials.
|
2007
|
1.04
|
|
41
|
Neovascularization and angiogenic gene expression following chronic arsenic exposure in mice.
|
2005
|
1.04
|
|
42
|
NF-kappaB in cardiovascular disease: diverse and specific effects of a "general" transcription factor?
|
2005
|
1.04
|
|
43
|
Quo vadis: whither homocysteine research?
|
2009
|
1.04
|
|
44
|
Cardiac safety of liposomal anthracyclines.
|
2007
|
1.03
|
|
45
|
Mitochondrial involvement in cardiac apoptosis during ischemia and reperfusion: can we close the box?
|
2009
|
1.02
|
|
46
|
Perinatal tobacco smoke exposure increases vascular oxidative stress and mitochondrial damage in non-human primates.
|
2010
|
1.01
|
|
47
|
Cardiovascular toxicities upon manganese exposure.
|
2005
|
1.01
|
|
48
|
Clinical aspects of endothelial dysfunction associated with human immunodeficiency virus infection and antiretroviral agents.
|
2004
|
1.01
|
|
49
|
Increase in cardiovascular pathology in female Sprague-Dawley rats following chronic treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3,3',4,4',5-pentachlorobiphenyl.
|
2003
|
1.01
|
|
50
|
Arsenic exposure and cardiovascular disorders: an overview.
|
2009
|
1.00
|